Bank of Nova Scotia’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$578K Sell
5,274
-1,015
-16% -$145K ﹤0.01% 888
2025
Q4
$1.05M Sell
6,289
-42,911
-87% -$7.18M ﹤0.01% 883
2025
Q3
$9.63M Sell
49,200
-428,800
-90% -$70.5M 0.02% 430
2025
Q2
$43.2M Sell
478,000
-486,400
-50% -$38.4M 0.09% 163
2025
Q1
$57.5M Buy
964,400
+939,300
+3,742% +$86.9M 0.13% 135
2024
Q4
$3.32M Buy
+25,100
New +$2.36M 0.01% 606

Other funds holding ALAB

Bank of Nova Scotia's ALAB Position: Q1 2026 in Review

Bank of Nova Scotia reduced its Astera Labs (ALAB) stake by 16% in Q1 2026, selling an estimated $145K and leaving 5,274 shares worth $578K. The position accounts for ﹤0.01% of the portfolio, ranked #888.

Bank of Nova Scotia first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $57.5M in Q1 2025. 704 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Bank of Nova Scotia held 5,274 shares of Astera Labs worth $578K as of Q1 2026.
  • Bank of Nova Scotia sold 1,015 Astera Labs shares in Q1 2026, an estimated $145K.
  • Astera Labs made up ﹤0.01% of Bank of Nova Scotia's portfolio in Q1 2026, its #888 holding.
  • Bank of Nova Scotia first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • Bank of Nova Scotia's Astera Labs position peaked at $57.5M in Q1 2025.
  • 704 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.